Alpha 2.0
Login Register
» Authors » F Maccari

F Maccari

Explore the profile of F Maccari including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 66
Citations 411
Followers 0
Related Specialties
Infectious Diseases
Dermatology
Biochemistry
Top 10 Co-Authors
E Mahe
M T Ramacci
Z Reguiai
A Beauchet
A-C Fougerousse
H Barthelemy
E Esteve
G Chaby
J Parier
E Begon
Published In
Ann Dermatol Venereol
J Eur Acad Dermatol Venereol
Biochim Biophys Acta
Metab Brain Dis
Arzneimittelforschung
Affiliations
Soon will be listed here.
Recent Articles
1.
Real-life management of psoriasis with biological agents during pregnancy
Tran C, Mahe E, Beylot-Barry M, Jullien D, Richard M, Fougerousse A, et al.
Ann Dermatol Venereol . 2024 Mar; 151(2):103254. PMID: 38554588
Background: French guidelines recommend stopping biologic treatment of psoriasis between 3 and 24 weeks before conception in accordance with the relevant Summary of Product Characteristics (SmPC). The aim of this...
2.
Hidradenitis suppurativa: Influence of hormonal factors on disease activity in women in France
Fougerousse A, Reguiai Z, Maccari F, Guillem P, Perrot J
Ann Dermatol Venereol . 2023 Aug; 150(4):274-275. PMID: 37652812
No abstract available.
3.
Janus kinase inhibitors for the treatment of atopic dermatitis: Real-life data on efficacy and safety in light of the Pharmacovigilance Risk Assessment Committee recommended measures
Reguiai Z, Becherel P, Fougerousse A, Chaby G, Perrot J, Begon E, et al.
J Eur Acad Dermatol Venereol . 2023 Jul; 37(11):e1307-e1309. PMID: 37415328
No abstract available.
4.
Dose spacing and reduction strategies in biotherapies for stable, clear or almost clear psoriasis: A survey of practices in France
Aubert H, Mahe E, Fougerousse A, Maccari F, Beneton N
Ann Dermatol Venereol . 2021 Dec; 149(1):68-70. PMID: 34887084
No abstract available.
5.
Systemic or biologic treatment in psoriasis patients does not increase the risk of a severe form of COVID-19
Fougerousse A, Perrussel M, Becherel P, Begon E, Pallure V, Zaraa I, et al.
J Eur Acad Dermatol Venereol . 2020 Jun; 34(11):e676-e679. PMID: 32564417
No abstract available.
6.
Effectiveness of secukinumab in hidradenitis suppurativa: an open study (20 cases)
Reguiai Z, Fougerousse A, Maccari F, Becherel P
J Eur Acad Dermatol Venereol . 2020 May; 34(11):e750-e751. PMID: 32401354
No abstract available.
7.
Effectiveness and short-term (16-week) tolerance of guselkumab for psoriasis under real-life conditions: a retrospective multicenter study
Fougerousse A, Ghislain P, Reguiai Z, Maccari F, Parier J, Bouilly Auvray D, et al.
J Eur Acad Dermatol Venereol . 2020 Apr; 34(10):e644-e646. PMID: 32314452
No abstract available.
8.
[Off-label drugs in childhood psoriasis]
Mahe E, Corgibet F, Maccari F, Hadj-Rabia S, Phan C, Ruer-Mulard M, et al.
Ann Dermatol Venereol . 2020 Apr; 147(6-7):429-438. PMID: 32299624
Introduction: Psoriasis affects 0.5% of children in Europe, with moderate to severe clinical forms in 15-35% of cases warranting the use of systemic treatments. Few treatments are licensed for childhood...
9.
Impact of patient psoriasis on partner quality of life, sexuality and empathy feelings: a study in 183 couples
Halioua B, Maccari F, Fougerousse A, Parier J, Reguiai Z, Taieb C, et al.
J Eur Acad Dermatol Venereol . 2020 Mar; 34(9):2044-2050. PMID: 32173921
Background: The impact of psoriasis on quality of life (QoL), sexuality and empathy requires better understanding in patient-partner relationships. Objectives: To evaluate the influence of psoriasis on partner QoL, presence...
10.
[Do psoriasis patients seen in private practice differ from those seen in hospitals?]
Amy de la Breteque M, Beauchet A, Maccari F, Ruer-Mulard M, Bastien M, Chaby G, et al.
Ann Dermatol Venereol . 2020 Jan; 147(4):310-312. PMID: 31952953
No abstract available.